Moderna shares plunge after leak of cancer vaccine data despite positive results
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release. This story matters for Finance & Markets readers tracking fund. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily fund signal